Instrument
🇰🇷 Samsung Biologics
KR (Korea) · 207940 · 삼성바이오로직스
Today's Score
0.50
neutral (yesterday 0.45)30-day score trend
📊 Quant score trend
Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)
PER 45.7 / PBR 8.21 / ROE 19.4% / 부채비율 48% / 이익률 45.4% / 매출성장 +30.3% / 이익성장 +64.7%
Not a buy or sell signal. Informational only.
📊 Latest earnings — 2026-03-31
Revenue
1.3T
YoY -2.5%
QoQ -72.4%
Operating income
580.8B
YoY +22.1%
Net income
—
YoY —
Informational — not a buy signal. Source: DART
🕸️ Metrics radar
Each axis is 0-100. Higher means stronger on that dimension.
Informational — 5 axes are 0-100 percentile, compared to sector average
Market regime — 🇰🇷 KR (Korea)
SIDE "이번 주 -7.0%. 큰 움직임 없이 어깨를 한 번 으쓱한 정도였어요."
📈 7-day price
📋 Recent filings (DART)
- 06-22 [기재정정]단일판매ㆍ공급계약체결
- 06-17 [기재정정]단일판매ㆍ공급계약체결
- 06-09 [기재정정]단일판매ㆍ공급계약체결
Source: DART (Korean electronic disclosure). Reference only.
📰 Recent news
-
한미 차남 임종훈, 신동국 대신 엄마 택했다…나우IB에 지분 매각 [시그...
07-02 · Naver
-
코스피 의약품業 시총 상반기 24조↓…대형주 감소 집중
07-02 · Naver
-
200만원 넘던 주가 5개월만에…"도대체 바닥이 어디냐" 눈물
07-02 · Naver
Source: Naver. Not Tradory's opinion.
🔎 Compare info
Click a button to see database-backed metrics. Informational only, not buy or sell signals.
ⓘ This compares public financial and market data. Not a buy or sell opinion.
See more after signing up
- • 5-year full chart (D/W/M/Y + RSI/MACD)
- • DCA simulation + market index comparison
- • Watchlist + email alerts
ⓘ Informational summary, not a buy or sell signal. Past data does not guarantee future returns.